Get the latest news alerts: at Twitter

Local Tech Wire

WINSTON-SALEM, N.C. — Targacept, Inc. (NASDAQ: TRGT), said Monday that it is being added to the NASDAQ Biotechnology Index (NASDAQ: NBI) on Nov. 23.

NASDAQ says the index includes securities of NASDAQ-listed companies that are classified as either biotechnology or pharmaceuticals and that meet other criteria, including a market capitalization of at least $200 million and an average daily trading volume of at least 100,000 shares.

Targacept is a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics.